ATE444080T1 - Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien - Google Patents

Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien

Info

Publication number: ATE444080T1
Authority: AT; Austria
Prior art keywords: substituted; alkyls; cycloalkyls; aryls; heteroalkyls
Prior art date: 1997-12-17

Application number

AT98963173T

Other languages

English (en)

Inventor

Richard Greenwald

Annapurna Pendri

Yun Choe

Samuel Zalipsky

Original Assignee

Enzon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-17

Filing date

1998-12-14

Publication date

2009-10-15

1998-12-14 Application filed by Enzon Inc filed Critical Enzon Inc

1998-12-14 Priority claimed from PCT/US1998/026565 external-priority patent/WO1999030727A1/en

2009-10-15 Application granted granted Critical

2009-10-15 Publication of ATE444080T1 publication Critical patent/ATE444080T1/de

Links

239000012867 bioactive agent Substances 0.000 title 1
239000012704 polymeric precursor Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 4
229940002612 prodrug Drugs 0.000 abstract 4
239000000651 prodrug Substances 0.000 abstract 4
-1 nitro- Chemical class 0.000 abstract 3
125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 abstract 2
125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
125000003107 substituted aryl group Chemical group 0.000 abstract 2
125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 2
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
230000000890 antigenic effect Effects 0.000 abstract 1
150000004945 aromatic hydrocarbons Chemical class 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
230000001588 bifunctional effect Effects 0.000 abstract 1
125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000004405 heteroalkoxy group Chemical group 0.000 abstract 1
125000004404 heteroalkyl group Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
125000005647 linker group Chemical group 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polyamides (AREA)

AT98963173T 1997-12-17 1998-12-14 Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien ATE444080T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US99243597A	1997-12-17	1997-12-17
US09/183,557 US6180095B1 (en)	1997-12-17	1998-10-30	Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
PCT/US1998/026565 WO1999030727A1 (en)	1997-12-17	1998-12-14	Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents

Publications (1)

Publication Number	Publication Date
ATE444080T1 true ATE444080T1 (de)	2009-10-15

Family

ID=25538340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98963173T ATE444080T1 (de)	1997-12-17	1998-12-14	Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien

Country Status (4)

Country	Link
US (1)	US6180095B1 (de)
EP (1)	EP1897561A1 (de)
AT (1)	ATE444080T1 (de)
DE (1)	DE69841206D1 (de)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100361933B1 (ko) *	1993-09-08	2003-02-14	라 졸라 파마슈티칼 컴파니	화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
WO1999030727A1 (en) *	1997-12-17	1999-06-24	Enzon, Inc.	Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
AU766190B2 (en) *	1998-10-16	2003-10-09	Biogen Idec Ma Inc.	Interferon-beta fusion proteins and uses
DK1656952T3 (da)	1998-10-16	2014-01-20	Biogen Idec Inc	Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf
US6458953B1 (en) *	1998-12-09	2002-10-01	La Jolla Pharmaceutical Company	Valency platform molecules comprising carbamate linkages
US7303760B2 (en) *	1999-04-23	2007-12-04	Alza Corporation	Method for treating multi-drug resistant tumors
HUP0201425A3 (en) *	1999-04-23	2006-07-28	Hadasit Med Res Service	Conjugate having a cleavable linkage for use in a liposome
US7238368B2 (en) *	1999-04-23	2007-07-03	Alza Corporation	Releasable linkage and compositions containing same
US6713454B1 (en)	1999-09-13	2004-03-30	Nobex Corporation	Prodrugs of etoposide and etoposide analogs
CA2414076A1 (en)	2000-06-08	2001-12-13	La Jolla Pharmaceutical Company	Multivalent platform molecules comprising high molecular weight polyethylene oxide
MXPA03000310A (es) *	2000-07-12	2004-12-13	Gryphon Therapeutics Inc	Quimiocinas sinteticas bioactivas, modificadas con polimeros y metodos para su elaboracion y uso.
US20030191291A1 (en) *	2000-09-08	2003-10-09	Kochendoerfer Gerd G.	Synthetic erythropoiesis stimulating proteins
US7118737B2 (en)	2000-09-08	2006-10-10	Amylin Pharmaceuticals, Inc.	Polymer-modified synthetic proteins
ATE378071T1 (de) *	2001-02-20	2007-11-15	Enzon Inc	Endgruppenverzweigte polymere verbindungen und diese enthaltende polymere konjugate
DK1379257T3 (da)	2001-03-23	2009-12-14	Enzon Inc	Anticancer-profarmakon anvendende substituerede aromatiske syrer
US20040077835A1 (en) *	2001-07-12	2004-04-22	Robin Offord	Chemokine receptor modulators, production and use
PT3025726T (pt) *	2002-01-18	2020-01-09	Biogen Ma Inc	Compostos do polímero polialquileno e utilizações dos mesmos
AU2003253890A1 (en) *	2002-07-12	2004-02-02	Biomarin Pharmaceutical Inc.	The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
US8129330B2 (en)	2002-09-30	2012-03-06	Mountain View Pharmaceuticals, Inc.	Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) *	2002-09-30	2004-04-01	Mountain View Pharmaceuticals, Inc.	Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040152769A1 (en) *	2002-11-09	2004-08-05	Ekwuribe Nnochiri Nkem	Modified carbamate-containing prodrugs and methods of synthesizing same
AU2003295432A1 (en) *	2002-11-12	2004-06-03	Enzon Pharmaceuticals, Inc.	Prodrugs of vancomycin with hydrolysis resistant polymer linkers
US8034900B2 (en) *	2002-12-30	2011-10-11	Amylin Pharmaceuticals, Inc.	Water-soluble thioester and selenoester compounds and methods for making and using the same
WO2004074345A2 (en) *	2003-02-19	2004-09-02	Pharmacia Corporation	Carbonate esters of polyethylene glycol activated by means of oxalate esters
US7332164B2 (en) *	2003-03-21	2008-02-19	Enzon Pharmaceuticals, Inc.	Heterobifunctional polymeric bioconjugates
AU2004230927B9 (en) *	2003-04-13	2011-12-01	Enzon Pharmaceuticals, Inc.	Polymeric oligonucleotide prodrugs
US20050249697A1 (en) *	2003-09-24	2005-11-10	Uhrich Kathryn E	Compositions and methods for the inhibition of bone growth and resorption
WO2005067644A2 (en) *	2004-01-07	2005-07-28	Ambit Biosciences Corporation	Conjugated small molecules
US7612153B2 (en) *	2004-10-25	2009-11-03	Intezyne Technologies, Inc.	Heterobifunctional poly(ethylene glycol) and uses thereof
EP1868652A2 (de)	2005-04-05	2007-12-26	Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A.	Verfahren zur abschirmung von funktionalen stellen oder epitopen auf proteinen
TWI381850B (zh) *	2005-12-30	2013-01-11	Pharmaessentia Corp	藥物與聚合物之共軛物
GB0604187D0 (en) *	2006-03-02	2006-04-12	Fusion Antibodies Ltd	Peptide and uses thereof
US7560588B2 (en)	2006-04-27	2009-07-14	Intezyne Technologies, Inc.	Poly(ethylene glycol) containing chemically disparate endgroups
CA2653748A1 (en)	2006-05-02	2007-11-15	Allozyne, Inc.	Non-natural amino acid substituted polypeptides
US20080096819A1 (en) *	2006-05-02	2008-04-24	Allozyne, Inc.	Amino acid substituted molecules
US20090156629A1 (en) *	2006-06-09	2009-06-18	Enzon Pharmaceuticals, Inc.	Indenoisoquinoline-releasable polymer conjugates
GB0611405D0 (en) *	2006-06-09	2006-07-19	Univ Belfast	FKBP-L: A novel inhibitor of angiogenesis
CN101484181B (zh) *	2006-06-30	2012-12-26	希格马托罕见疾病公司	用于生产l-天门冬酰胺酶ⅱ的重组宿主
CA2662520A1 (en) *	2006-09-15	2008-03-20	Enzon Pharmaceuticals, Inc.	Polymeric conjugates containing positively-charged moieties
US7985783B2 (en)	2006-09-21	2011-07-26	The Regents Of The University Of California	Aldehyde tags, uses thereof in site-specific protein modification
US20100279408A1 (en) *	2006-11-27	2010-11-04	Enzon Pharmaceuticals, Inc.	Polymeric short interfering rna conjugates
JP2010514803A (ja) *	2006-12-29	2010-05-06	エンゾンファーマスーティカルズインコーポレイテッド	肺疾患を治療するためのアデノシンデアミナーゼの使用方法
PL2147122T3 (pl) *	2007-04-20	2015-05-29	Leadiant Biosciences Ltd	Enzymatyczna terapia przeciwnowotworowa
HUE027603T2 (en) *	2007-04-20	2016-10-28	Sigma-Tau Rare Disease Ltd	Stable, recombinant adenosine deaminase
WO2009009716A1 (en) *	2007-07-11	2009-01-15	Enzon Pharmaceuticals, Inc.	Polymeric drug delivery systems containing an aromatic allylic acid
JP2010533202A (ja) *	2007-07-11	2010-10-21	エンゾンファーマシューティカルズ，インコーポレーテッド	多置換芳香族部分を含むポリマー性薬剤送達システム
CA2707840A1 (en) *	2007-08-20	2009-02-26	Allozyne, Inc.	Amino acid substituted molecules
JP5732453B2 (ja)	2009-06-25	2015-06-10	アルカーメスファーマアイルランドリミテッド	Ｎｈ酸性化合物のプロドラッグ
PT2445502T (pt)	2009-06-25	2017-09-22	Alkermes Pharma Ireland Ltd	Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
WO2011084850A1 (en) *	2010-01-07	2011-07-14	Alkermes, Inc.	Prodrugs for the treatment of schizophrenia and bipolar disease
US20110166128A1 (en) *	2010-01-07	2011-07-07	Alkermes, Inc.	Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders
EP2521711B1 (de) *	2010-01-07	2017-08-16	Alkermes Pharma Ireland Limited	Quartäre ammoniumsalz-prodrugs
EP2521545B1 (de)	2010-01-07	2019-11-27	Alkermes Pharma Ireland Limited	Prodrugs aus heteroaromatischen verbindungen
WO2011084851A1 (en) *	2010-01-07	2011-07-14	Alkermes, Inc.	Asenapine produrugs
NZ604423A (en)	2010-06-24	2015-01-30	Alkermes Pharma Ireland Ltd	Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
ES2866674T3 (es) *	2010-11-12	2021-10-19	Nektar Therapeutics	Conjugados de una fracción de IL-2 y un polímero
AU2011342896A1 (en)	2010-12-13	2013-07-04	Quiapeg Pharmaceuticals Ab	Functionalized polymers
MX347298B (es) *	2010-12-29	2017-04-21	Arrowhead Res Corp	Conjugados de suministro de polinucleotidos in vivo que tienen acoplamientos sensibles a enzima.
ES2972387T3 (es)	2011-03-18	2024-06-12	Alkermes Pharma Ireland Ltd	Composiciones farmacéuticas que comprenden ésteres de sorbitán
DE102011118029A1 (de)	2011-06-20	2012-12-20	Universität Leipzig	Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung
AU2012278944B2 (en)	2011-07-05	2015-09-17	Bioasis Technologies Inc.	p97-antibody conjugates and methods of use
WO2013088255A1 (en)	2011-12-15	2013-06-20	Alkermes Pharma Ireland Limited	Prodrugs of secondary amine compounds
CA2867121C (en)	2012-03-19	2021-05-25	Alkermes Pharma Ireland Limited	Pharmaceutical compositions comprising fatty acid esters
WO2013142202A1 (en)	2012-03-19	2013-09-26	Alkermes Pharma Ireland Limited	Pharmaceutical compositions comprising glycerol esters
US9999670B2 (en)	2012-03-19	2018-06-19	Alkermes Pharma Ireland Limited	Pharmaceutical compositions comprising benzyl alcohol
AU2013276219B2 (en)	2012-06-12	2018-03-08	Quiapeg Pharmaceuticals Ab	Conjugates of biologically active molecules to functionalized polymers
WO2014022515A1 (en)	2012-07-31	2014-02-06	Bioasis Technologies, Inc.	Dephosphorylated lysosomal storage disease proteins and methods of use thereof
JP6654042B2 (ja)	2012-09-19	2020-02-26	アルカームスファーマアイルランドリミテッド	貯蔵安定性が改善された医薬組成物
WO2014078733A1 (en)	2012-11-16	2014-05-22	The Regents Of The University Of California	Pictet-spengler ligation for protein chemical modification
US9310374B2 (en)	2012-11-16	2016-04-12	Redwood Bioscience, Inc.	Hydrazinyl-indole compounds and methods for producing a conjugate
NZ711373A (en)	2013-03-13	2020-07-31	Bioasis Technologies Inc	Fragments of p97 and uses thereof
US20150093399A1 (en)	2013-08-28	2015-04-02	Bioasis Technologies, Inc.	Cns-targeted conjugates having modified fc regions and methods of use thereof
CN115504924A (zh)	2013-11-27	2022-12-23	雷德伍德生物科技股份有限公司	肼基-吡咯并化合物及用于生成缀合物的方法
EP3110448B1 (de)	2014-02-26	2020-09-09	The Board of Regents of The University of Texas System	Nitrobenzaldehydprotonfreisetzung zur manipulation von zellulärer azidose
AU2015231278B2 (en)	2014-03-20	2020-01-23	Alkermes Pharma Ireland Limited	Aripiprazole formulations having increased injection speeds
AU2015332533B2 (en)	2014-10-14	2018-08-30	Halozyme, Inc.	Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
WO2017062832A1 (en)	2015-10-08	2017-04-13	Nektar Therapeutics	Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist
WO2017083306A1 (en)	2015-11-09	2017-05-18	R.P. Scherer Technologies, Llc	Anti-cd22 antibody-maytansine conjugates and methods of use thereof
WO2017180998A2 (en)	2016-04-15	2017-10-19	Beckman Coulter, Inc.	Photoactive macromolecules and uses thereof
DK3463308T4 (da)	2016-06-01	2026-02-09	Servier Ip Uk Ltd	Formuleringer af polyalkylenoxid-asparaginase og fremgangsmåder til fremstilling og anvendelse deraf
KR20220147719A (ko)	2016-11-14	2022-11-03	항저우 디에이씨 바이오테크 씨오, 엘티디	결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN109923179A (zh)	2016-12-12	2019-06-21	贝克顿·迪金森公司	水溶性聚合物染料
CN108727208B (zh) *	2017-03-07	2020-06-30	天津键凯科技有限公司	一种连接子化合物、聚乙二醇-连接子结合物及其衍生物和聚乙二醇-连接子-药物结合物
CN110545850A (zh)	2017-03-10	2019-12-06	奎亚培格制药公司	可释放的缀合物
US12344645B2 (en)	2017-03-29	2025-07-01	Polaris Group	Protein conjugates
JP7022328B2 (ja)	2017-03-30	2022-02-18	日油株式会社	自壊性アセタールリンカーを有する親水性ポリマー誘導体及びそれを用いた複合体
JP7338873B2 (ja)	2017-07-19	2023-09-05	ユニケリス・リミテッド	強皮症関連血管障害を治療または改善するための組成物および方法
EP4257198A3 (de)	2017-08-22	2023-10-18	Dynavax Technologies Corporation	Alkylkettenmodifizierte imidazochinolin-derivate als tlr7/8-agonisten und verwendungen davon
CN109589415B (zh) *	2017-09-30	2022-02-18	天津键凯科技有限公司	一种聚乙二醇-多肽和蛋白类药物的结合物
CN114668852A (zh) *	2017-09-30	2022-06-28	天津键凯科技有限公司	一种聚乙二醇-多肽和蛋白类药物的结合物
US10722591B2 (en)	2017-11-14	2020-07-28	Dynavax Technologies Corporation	Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof
WO2019133399A1 (en)	2017-12-26	2019-07-04	Becton, Dickinson And Company	Deep ultraviolet-excitable water-solvated polymeric dyes
AU2019230014B2 (en)	2018-03-05	2024-11-28	Alkermes Pharma Ireland Limited	Aripiprazole dosing strategy
CN112384573A (zh)	2018-03-30	2021-02-19	贝克顿·迪金森公司	含侧基发色团的水溶性聚合染料
EP3813867A1 (de)	2018-07-22	2021-05-05	Bioasis Technologies Inc.	Behandlung von lymphatischen metastasen
EP3849660A1 (de)	2018-09-12	2021-07-21	QuiaPEG Pharmaceuticals AB	Lösbare glp-1-konjugate
EP3909612A1 (de)	2020-05-12	2021-11-17	Life Science Inkubator Betriebs GmbH & Co. KG	Zusammensetzung von nanopartikeln
US20210355468A1 (en)	2020-05-18	2021-11-18	Bioasis Technologies, Inc.	Compositions and methods for treating lewy body dementia
US20210393787A1 (en)	2020-06-17	2021-12-23	Bioasis Technologies, Inc.	Compositions and methods for treating frontotemporal dementia
CA3128035A1 (en)	2020-08-13	2022-02-13	Bioasis Technologies, Inc.	Combination therapies for delivery across the blood brain barrier
EP4155349A1 (de)	2021-09-24	2023-03-29	Becton, Dickinson and Company	Wasserlösliche gelbe grünabsorbierende farbstoffe
CN117980327A (zh)	2021-11-03	2024-05-03	杭州多禧生物科技有限公司	抗体的特异性偶联
US20250383357A1 (en)	2022-07-01	2025-12-18	Beckman Coulter, Inc.	Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
WO2024044327A1 (en)	2022-08-26	2024-02-29	Beckman Coulter, Inc.	Dhnt monomers and polymer dyes with modified photophysical properties
WO2024196805A1 (en)	2023-03-17	2024-09-26	Beckman Coulter, Inc.	Benzothienopyrrole cyanine dyes
CN121866309A (zh)	2023-09-21	2026-04-14	贝克曼库尔特有限公司	用于流式细胞术的二氢菲（dhp）桥接染料

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
JP2958019B2 (ja)	1988-05-06	1999-10-06	住友製薬株式会社	ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法
US5122614A (en)	1989-04-19	1992-06-16	Enzon, Inc.	Active carbonates of polyalkylene oxides for modification of polypeptides
FR2676058B1 (fr)	1991-04-30	1994-02-25	Hoechst Lab	Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
US5614549A (en) *	1992-08-21	1997-03-25	Enzon, Inc.	High molecular weight polymer-based prodrugs
US5382657A (en) *	1992-08-26	1995-01-17	Hoffmann-La Roche Inc.	Peg-interferon conjugates
JP3026133B2 (ja) *	1992-11-05	2000-03-27	コニカ株式会社	ハロゲン化銀写真感光材料
US5349001A (en)	1993-01-19	1994-09-20	Enzon, Inc.	Cyclic imide thione activated polyalkylene oxides
US5321095A (en)	1993-02-02	1994-06-14	Enzon, Inc.	Azlactone activated polyalkylene oxides
ES2148259T3 (es) *	1993-09-22	2000-10-16	Hoechst Ag	Pro-profarmacos, su produccion y uso.
US5840900A (en) *	1993-10-20	1998-11-24	Enzon, Inc.	High molecular weight polymer-based prodrugs
US5605976A (en)	1995-05-15	1997-02-25	Enzon, Inc.	Method of preparing polyalkylene oxide carboxylic acids
US5643575A (en)	1993-10-27	1997-07-01	Enzon, Inc.	Non-antigenic branched polymer conjugates
US5672584A (en)	1995-04-25	1997-09-30	The University Of Kansas	Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
DE69533615T2 (de)	1995-06-27	2005-10-13	Pharmachemie B.V.	Anthracyclin Prodrugs, Verfahren zu deren Herstellung und deren Verwendung in der selektiven Chemotherapie
AU739028B2 (en)	1996-09-27	2001-10-04	Bristol-Myers Squibb Company	Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
US5965119A (en) *	1997-12-30	1999-10-12	Enzon, Inc.	Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents

1998
- 1998-10-30 US US09/183,557 patent/US6180095B1/en not_active Expired - Lifetime
- 1998-12-14 AT AT98963173T patent/ATE444080T1/de not_active IP Right Cessation
- 1998-12-14 DE DE69841206T patent/DE69841206D1/de not_active Expired - Lifetime
- 1998-12-14 EP EP07117973A patent/EP1897561A1/de not_active Ceased

Also Published As

Publication number	Publication date
DE69841206D1 (de)	2009-11-12
EP1897561A1 (de)	2008-03-12
US6180095B1 (en)	2001-01-30

Legal Events

Date	Code	Title	Description
2010-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69841206D1 (de)	2009-11-12	Polymere vorstufenwirkstoffe von amino-und hydroxyl-enthaltenden bioaktiven agentien
DK1041995T3 (da)	2006-07-10	Trialkyl-blokeringsfaciliterede polymere prolægemidler af amino-indeholdende bioaktive midler
DK0581452T3 (da)	1998-05-04	Vaskemiddelsammensætninger med polysuccinimid
ATE102966T1 (de)	1994-04-15	Blockcopolyester mit verzweigten hydrophilen endgruppen, verwendbar als schmutzentfernungsmittel in waschmittelzusammensetzungen.
CA2312975A1 (en)	1999-06-24	Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
NO20020725D0 (no)	2002-02-13	Celleadhesjonsinhibitorer
DE69739853D1 (de)	2010-06-02	Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen
DE59105815D1 (de)	1995-08-03	1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
MX9305489A (es)	1994-03-31	3-(dihidrobenzofuran-5-il)benzofuran-2-onas, estabilizadores.
CY1105811T1 (el)	2011-02-02	Ενωσεις ενισχυτη ταξολης
RU2001117824A (ru)	2003-09-20	Блоксополимеры на основе винилциклогексана
ES2189249T3 (es)	2003-07-01	Com`posiciones polimeras acuosas estables que contienen poli(alquileniminas).
CO5060545A1 (es)	2001-07-30	Poliamida inherente estabilizada frente a la luz y al calor y metodo para su obtencion
MX9206247A (es)	1993-05-01	Agentes de transferencia de cadena de mercaptano latentes de tiol y su empleo en la sintesis de polimeros.
ES2160253T3 (es)	2001-11-01	Agentes de enjuagado-aclarado con polimeros cationicos.
DE69500597D1 (de)	1997-10-02	N-pyridyl Carboxamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
ES2056146T3 (es)	1994-10-01	Monopersulfatos de acidos amino-(poli)percarboxilicos.
DE59707524D1 (de)	2002-07-18	1,3-bis-(n-lactamyl)propane und deren pharmazeutische und kosmetische verwendung
DE60233315D1 (de)	2009-09-24	Prodrugs von krebsmitteln mit substituierten aromatischen säuren
BR9708639A (pt)	1999-04-13	Composição estabilizadora
BR9804309A (pt)	1999-12-07	Tensoativos
ES2187565T3 (es)	2003-06-16	Alcaloides indolicos utiles como agentes antiinflamatorios.
BR8906510A (pt)	1990-08-28	Mistura de polimeros,recipiente e processo para a protecao de materiais dos gases ambientais
ATE203510T1 (de)	2001-08-15	Multifunktionelle vinylcyclopropan-derivate
EP1484322A4 (de)	2008-01-23	Verfahren zur herstellung eines optisch aktiven sulfoxid derivats